Manchester Neurodevelopmental Pharmacovigilance Research Group, University of Manchester

We are a research group based across the University of Manchester and Royal Manchester Children’s Hospital which is concerned with the investigation of the longer-term outcomes of children exposed to medications in utero. We work closely with Other pharmacovigilance groups on investigations into the potentially later emerging risks following exposure in the womb including child health,cognitive,social,motor,clinical disorders and behavioural outcomes.